Standard‐dose adrenaline (SDA) may leads to higher survival to hospital admission compared with vasopressin (low certainty).
It is very uncertain whether standard‐dose adrenaline (SDA) changes favourable neurological outcomes compared with vasopressin (very low certainty).
It is very uncertain whether standard‐dose adrenaline (SDA) changes return of spontaneous circulation compared with vasopressin (very low certainty).
It is very uncertain whether standard‐dose adrenaline (SDA) changes survival to hospital discharge compared with SDA plus vasopressin (very low certainty).
Standard‐dose adrenaline (SDA) showed no clear difference in survival to hospital admission compared with SDA plus vasopressin (low certainty).
It is very uncertain whether standard‐dose adrenaline (SDA) changes favourable neurological outcomes compared with SDA plus vasopressin (very low certainty).
Standard‐dose adrenaline (SDA) showed no clear difference in return of spontaneous circulation compared with SDA plus vasopressin (low certainty).
It is very uncertain whether standard‐dose adrenaline (SDA) changes survival to hospital discharge compared with vasopressin (very low certainty).
Standard‐dose adrenaline (SDA) probably leads to higher survival to hospital discharge compared with placebo (moderate certainty).
Standard‐dose adrenaline (SDA) probably leads to higher survival to hospital admission compared with placebo (moderate certainty).
Standard‐dose adrenaline (SDA) showed no clear difference in favourable neurological outcomes compared with placebo (low certainty).
Standard‐dose adrenaline (SDA) probably leads to higher return of spontaneous circulation compared with placebo (moderate certainty).
It is very uncertain whether standard‐dose adrenaline (SDA) changes survival to hospital discharge compared with high‐dose adrenaline (HDA) (very low certainty).
It is very uncertain whether standard‐dose adrenaline (SDA) changes survival to hospital admission compared with high‐dose adrenaline (HDA) (very low certainty).
It is very uncertain whether standard‐dose adrenaline (SDA) changes favourable neurological outcomes compared with high‐dose adrenaline (HDA) (very low certainty).
It is very uncertain whether standard‐dose adrenaline (SDA) changes return of spontaneous circulation compared with high‐dose adrenaline (HDA) (very low certainty).